A Danish cost-effectiveness model of escitalopram in comparison with citalopram and venlafaxine as first-line treatments for major depressive disorder in primary care

By Sørensen Jan   Stage Kurt   Damsbo Niels   Lay Agathe Le   Hemels Michiel  

Nordic Journal of Psychiatry, Vol. 61, Iss. 2, 2007-01 ,pp. : 100-108

Informa Healthcare

Access to resources Recommend Favorite

Escitalopram in major depressive disorder: clinical benefits and cost effectiveness versus citalopram

By Lançon Christophe   Verpillat Patrice   Annemans Lieven   Despiegel Nicolas   François Clément  

International Journal of Psychiatry in Clinical Practice, Vol. 11, Iss. 1, 2007-01 ,pp. : 44-52

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Escitalopram in the Long-term Treatment of Major Depressive Disorder

By Wade Alan   Despiegel Nicolas   Heldbo Reines Elin  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 18, Iss. 2, 2006-05 ,pp. : 83-89

Informa Healthcare

Access to resources Recommend Favorite

A cost-effectiveness analysis of escitalopram as first line treatment of depression in Sweden

By Löthgren Mickael   Hemels Michiel   François Clément   Jönsson Bengt  

Primary Care Psychiatry, Vol. 9, Iss. 4, 2004-12 ,pp. : 153-162

Informa Healthcare

Access to resources Recommend Favorite

Effectiveness of antidepressants in the treatment of major depressive disorder in Latin America

By Dueñas Héctor J.   Dwight Trisha   McBride Margaret E.   Brnabic Alan J.M.   Semper Luis A.   Holmgren Dagmar   Miranda-Scippa Angela M.A.   Rincón Hernán G.   Aguilera Héctor   Vargas Adrian  

International Journal of Psychiatry in Clinical Practice, Vol. 11, Iss. 2, 2007-01 ,pp. : 129-139

Ashgate Publishing Ltd

Access to resources Recommend Favorite